The Atlanta Braves decided not to re-sign veteran pitcher Charlie Morton this offseason, a move that drew mixed reactions from fans. Morton had played a key role in the team’s rotation in recent years, and many had hoped he would return. Between 2021 and 2024, he threw 686.1 innings for the Braves, maintaining a 3.87 ERA with 771 strikeouts and 269 walks—impressive stats for a pitcher in the later stages of his career. However, concerns over his inconsistency during the 2024 season influenced the team’s decision not to bring him back for 2025.
Their choice appears justified in hindsight, as Morton has struggled significantly after signing a one-year, $15 million contract with the Baltimore Orioles. So far, he’s 0-7 with a 9.38 ERA over 31.2 innings, leading MLB in earned runs allowed (33) and the American League in walks (22). Although his age—now 41—might be contributing, the severity of his decline has still been unexpected.
/cdn.vox-cdn.com/uploads/chorus_image/image/73106528/1687491709.0.jpg)
A closer look at the underlying numbers helps explain the downturn. Morton’s once-elite curveball has fallen off dramatically. According to Statcast, the pitch that used to rank in the 100th percentile now sits in the 1st percentile. Last season, opponents hit just .198 against it. This year, they’re batting .357 with a .667 slugging percentage
Morton’s decline has also shown up in his groundball rate. After ranking in the 75th percentile with a 47.2% rate in 2024, that figure has dropped to the 39th percentile in 2025. Additionally, his breaking ball effectiveness has deteriorated, with its run value falling from +2 to -7.
Interestingly, opposing hitters are struggling against his fastball, managing just a .171 batting average—even though it only averages 93.8 mph. However, the lack of effectiveness in his secondary pitches has led to poor overall performance.
Though Morton is still valued for his leadership and veteran presence, it’s becoming evident that age may finally be taking its toll.
